Evaluation of bioactivity, safety, toxicology and mechanisms of action of functional ingredients through the design of in vitro and in vivo assays.

 • Evaluation of bioactivity, safety, toxicology and mechanism of action through in vitro models: microbiological studies, cell viability, digestion simulation models, genomics and proteomics.

 • Preclinical studies in animal models.

 • Nutritional assays in humans to determine the potential health benefits, mechanisms of action, bioavailability, etc, of the bioactive compounds under study.

 • Clinical human assays to evaluate safety, pharmacokinetics tolerance, mechanisms of action, etc, of the bioactive compounds under study.

 • Multicenter clinical trials using inpatient and/or outpatient procedures.